维普期刊资源整合服务平台（V6.5）

87篇 您的检索式：作者名="Papapoulos"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	The use of bisphosphonate in the treatment of osteoporosis显示文摘	PAPAPOULOS S E LANDMAN J O BIJVOET O L	1992	Bone1992，13，1：	1
2	Ueroxisome proliferator- activated receptor gamma(PPARgamma) as a molecular target for the soy phvtoestrogen genistein显示文摘	Dang ZC Audlnot V Papapoulos SE etal	2003	J Biol Chem2003，278，2：	1
3	Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro显示文摘	Van Bezooijen RL van der Wee-Pals L Papapoulos SE	2002	Ann Rheum Dis2002，61，：	1
4	IL-17 : Anew bone acting cytokine in Vitro显示文摘	Van bezooijen RL Farih-Sips HC Papapoulos SE	1999	J Bone Miner Res1999，14，9：	1
5	Scleros- tin: current knowledge and future perspectives显示文摘	Moester MJ Papapoulos SE Lowik CW	2010	Calcif Tissue Int2010，87，2：	1
6	Increased bone mass with pamidronate treatment in rheumatoid arthritis : Results of a threeyear randomized, double-blind trial 显示文摘	Eggelmeijer F Papapoulos SE van PH	1996	Arthritis Rheum1996，39，3：	1
7	Targeting sclerostin as potential treatment of osteoporosis显示文摘	Papapoulos SE	2011	Ann Rheum Dis2011，70，1：	1
8	Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women显示文摘	Papapoulos SE Quandt SA Liberman UA		0，，05：	1
9	Prolonged bisphosphonate release after treatment in children显示文摘	Papapoulos SE Cremers SC	2007	N Engl J Med2007，356，10：	1
10	Targeting sclerostin as potential treat ment of osteoporosis显示文摘	Papapoulos SE	2011	Ann Rheum Dis2011，70，：	1
11	The use of bisphosphonate in the treatment of osteoporosis显示文摘	Papapoulos SE Landman JO Bijvoet OL	1992	Bone1992，3，1：	1
12	Clinical risk factors as predictors of postmenopausal osteoporosis in general practice显示文摘	Versluis RG Papapoulos SE Zwinderman AH		0，，：	1
13	SOST/sclerostin,an osteocyte-derived negative regulator of bone formation显示文摘	van Bezooijen RL ten Dijke P Papapoulos SE		0，，：	1
14	Interleukin 17 synergises with tumour necrosis factor 'alpha to induce cartilage destruction in vitro显示文摘	Van Bezooijen RL van der Wee-pals L Papapoulos SE	2002	Ann Rheum Dis2002，61，10：	1
15	Sclerostin:Current knowledge and future perspectives显示文摘	Moester MJ Papapoulos SE L(o)wik CW		0，，02：	1
16	Five years of denosumab exposure in women with postmenopausal ostcoporosis: Results from the first two years of the FREEDOM extension显示文摘	Papapoulos S Chapurlat R Libanati C	2012	J Bone Miner Res2012，27，：	1
17	Selection of antiresorptive or anabolictreatments for postmenopausal osteoporosis 显示文摘	Papapoulos S Makras P	2008	Nat Clin PractEndocrinol Metab2008，4，9：	1
18	Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis:a double blind placebo controlled study显示文摘	Eggelmeijer F Papapoulos SE van Paassen HC	1994	J Rheumatol1994，21，11：	1
19	Bone diseases:Bisphosphonates in osteoporosis-beyond 5 years显示文摘	Papapoulos SE		0，，：	1
20	Atypical subtrochanteric and diaphyseal femoral fractures:Second report of a task force of the American Society for Bone and Mineral Research显示文摘	Shane E Burr D Abrahamsen B Adler RA Brown TD Cheung AM Cosman F Curtis JR Dell R Dempster DW Ebeling PR Einhorn TA Genant HK Geusens P Klaushofer K Lane JM McKiernan F McKinney R Ng A Nieves J O'Keefe R Papapoulos S Howe TS van der Meulen MC Weinstein RS		0，，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示